Beneficial effects of circulating progenitor endothelial cells activated by angiotensin receptor antagonists.
Levy
Bernard I
BI
D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D002452:Cell Count; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology; D042783:Endothelial Cells / Q000187:drug effects*; D006412:Hematopoietic Stem Cells / Q000187:drug effects*; D006801:Humans
D047228:Angiotensin II Type 1 Receptor Blockers